KEY TAKEAWAY: A two minute story on the evening news about a new cancer drug doesn’t answer enough questions for people who may want to know more before meeting with their doctor. Biopharma companies need to set realistic expectations when it comes to new drugs and they need to be a credible source of medical information for patients, but all too often their websites are a billboard that says “ask your doctor about me”. Continue reading
KEY TAKEAWAY: DTC TV ads can produce results, but it’s essential to drive patients into the doctor to ask for your drug while educating physicians on the telltale symptoms of the disease state you are marketing to. Continue reading
KEY TAKEAWAY: Pharma is ingrained in a culture of meetings and presentations. It’s been that way for over 20 years and is part of a matrix environment that shares decision making and waters down key initiatives. However, DTC marketers can ensure success by asking these three questions. Continue reading
Here’s what will happen if the American Health Care Act becomes law. Tens of millions of Americans will lose health coverage and tens of thousands of people will die every year who otherwise would have lived. It’s time for the voices that have been silent to yell and stop this insanity before it’s too late. Continue reading
Yesterday, while at the airport, I received a phone call that nobody should ever have to get. My brother-in-law, with whom we were very close,passed away at the young age of 52. Continue reading
John Henning Schumann is an internal medicine doctor and serves as president of the University of Oklahoma’s Tulsa campus. He recently wrote an article entitled “Those TV Drug Ads Distract Us From The Medical Care We Need“. Although he has some valid points he fails to recognize that patients want to control conversations around what they perceive is THEIR healthcare.
KEY TAKEAWAY: Patients and caregivers want to better understand chronic health conditions and, more importantly, what to expect when evaluating different treatment options. With the increase in “fake news” pharma companies have an opportunity to really engage their audience if they can think beyond “what’s the ROI?”. Continue reading